Efficacite de trois techniques de chirurgie bariatrique chez des sujets obeses diabetiques de type 2.

[en] This retrospective work compares the efficacy of three procedures of bariatric surgery in obese patients with type 2 diabetes : gastric bypass (n = 22), sleeve gastrectomy (n = 18) and Magenstrasse & Mill gastroplasty (also known as reversible sleeve (n = 19). The three interventions result in a remarkable weight loss after one year, a better glycaemic control, with often a remission of diabetes, a reduction of blood pressure and an improvement of lipid profile, allowing an interruption or a dose reduction of concomitant medications. Overall, classical sleeve provides almost similar results as gastric bypass and appears slightly better than reversible sleeve. These results deserve confirmation in studies with more patients followed for a longer term.

Disciplines :

Gastroenterology & hepatology
Endocrinology, metabolism & nutrition

Author, co-author :

Bessemans, Severine

Scheen, André ; Université de Liège > Département des sciences cliniques > Département des sciences cliniques

Language :

French

Title :

Efficacite de trois techniques de chirurgie bariatrique chez des sujets obeses diabetiques de type 2.

Alternative titles :

[en] Comparative efficacy of three bariatric surgery procedures in obese patients with type 2 diabetes

Publication date :

2016

Journal title :

Revue Médicale Suisse

ISSN :

1660-9379

Publisher :

Medecine et Hygiène, Switzerland

Volume :

Issue :

527

Pages :

1378-1382

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 08 September 2017

Statistics

Number of views

374 (6 by ULiège)

Number of downloads

522 (14 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Scheen AJ, Van Gaal LF. Combating the dual burden: Therapeutic targeting of common pathways in obesity and type 2 diabetes. Lancet Diabetes Endocrinol 2014 ;2:911-22.
Scheen AJ. Aggressive weight reduction treatment in the management of Type 2 diabetes. Diabetes Metab 1998 ;24:116-23.
Scheen AJ, De Flines J, De Roover A, et al. Bariatric surgery in patients with zype 2 diabetes: Benefits, risks, indications and perspectives. Diabetes Metab 2009 ;35:537-43.
Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet 2012 ;379:2300-11.
De Flines J, Franck M, Rorive M, et al. Chirurgie métabolique: une place croissante dans le traitement du diabète. Rev Med Suisse 2012 ;8:1621-7.
Suter M, Giusti V. Chirurgie bariatrique en 2013: principes, avantages et inconvenients des interventions à disposition. Rev Med Suisse 2013 ;9:658-63.
Li J, Lai D, Wu D. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: A systematic review and meta-analysis. Obes Surg 2016 ;26:429-42.
Vidal J, Jimenez A, de Hollanda A, et al. Metabolic surgery in type 2 diabetes: Roux-en-Y gastric bypass or sleeve gastrectomy as procedure of choice? Curr Atheroscler Rep 2015 ;17:58.
De Roover A, Kohnen L, Deflines J, et al. Laparoscopic Magenstrasse and Mill gastroplasty. First results of a prospective study. Obes Surg 2015 ;25:234-41.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012 ;366:1567-76.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014 ;370:2002-13.
Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: A randomised trial. Diabetologia 2013 ;56:1914-8.
Arroyo K, Alkhoury F, Nadzam G, et al. Magenstrasse and Mill gastroplasty and sleeve gastrectomy as treatment for morbid obesity. Conn Med 2010 ;74:589-93.
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009 ;32:2133-5.
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004 ;351:2683-93.
Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial-a prospective controlled intervention study of bariatric surgery. J Intern Med 2013 ;273:219-34.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012 ;366:1577-85.
Johnston D, Dachtler J, Sue-Ling HM, et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg 2003 ;13:10-6.
Robinson J, Sue-Ling H, Johnston D. The Magenstrasse and Mill procedure can be combined with a Roux-en-Y gastric bypass to produce greater and sustained weight loss. Obes Surg 2006 ;16:891-6.
Pham S, Gancel A, Scotte M, et al. Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: A retrospective study. J Obes 2014 ;2014:638203.
Li JF, Lai DD, Ni B, et al. Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Can J Surg 2013 ;56: E158-64.
Cho JM, Kim HJ, Lo Menzo E, et al. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: Systemic review and meta-analysis. Surg Obes Relat Dis 2015 ;11:1273-80.
Panunzi S, Carlsson L, De Gaetano A, et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care 2016 ;39:166-74.
Luyckx FH, Scheen AJ, Desaive C, et al. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 1998 ;24: 355-61.